NCT01508897 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Comparison of Two Liraglutide Formulations in Healthy Volunteers


Sponsors: Novo Nordisk	Phases: Phase I
Indications	Acronym:
Diabetes Healthy
Age Groups: Adult	Gender:
Names: Drug: liraglutide Drug: liraglutide	Enrollment: 22

Additional information about NCT01508897.